Micro-Invasive Glaucoma Surgery (MIGS)
The treatment for glaucoma has come a long way. Today’s advanced technologies and procedures make it possible to diagnose and successfully manage this progressive disease. And while the overall goal of treatment has always remained the same — reducing intraocular pressure (IOP) and glaucomatous progression — Micro-Invasive Glaucoma Surgery (MIGS) is quickly becoming a widely accepted approach for treating mild-to-moderate glaucoma.
Glaucoma Therapy Advances
Glaucoma is primarily managed with prescription eye drops. If a patient’s glaucoma progresses or the patient stops responding to the eye drops, a surgical solution is offered. These surgical solutions are often highly invasive, require long recovery times, and could result in long-term complications.
As technology has progressed, less invasive techniques have emerged that have improved the safety profile for glaucoma surgery. This opened more surgical options for patients interested in effective glaucoma management which does not rely solely on the continuous use of prescription medication.
With the FDA approval of the iStent®, Micro-Invasive Glaucoma Surgery (MIGS) became a preferred approach to glaucoma management for many eye care professionals and their patients with mild-to-moderate glaucoma.
Now, with the FDA approval of iStent inject® – the smallest medical device known to be implanted in the human body—is made of two tiny stents that are designed to restore your eye’s natural ability to drain fluid out of the eye to reduce glaucoma pressure. Designed for cataract patients with glaucoma, iStent inject® is implanted at the time of cataract surgery. You won’t see or feel the iStent inject® stents after they are inserted, but they are designed to effectively manage your eye pressure.
How iStent inject® Works
Similar to cardiac stents used in patients with heart problems, the iStent opens pressure drainage channels in the eye, permanently treating glaucoma. To help control the increased pressure in your eye associated with glaucoma, iStent inject® creates two bypasses, or openings, between the front part of your eye and its natural drainage pathway to increase the flow of fluid. By creating the permanent bypasses through the primary blockage site (trabecular meshwork), iStent inject® is designed to:
• Improve your eye’s natural outflow to safely lower intraocular pressure
• Work continuously to improve the natural flow of fluid in your eyes
If you or a family member has glaucoma. Please contact us today for a consutation to discuss whether iStent or other treatments for glaucoma is an option for you. You may fill out our web form, or if you prefer, call 301.896.0890 to schedule a consultation with Dr. Thandeka Myeni.